<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pharmalicensing.com: PR Newswire</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>Pharmalicensing.com: PR Newswire</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.gif</url>
			<width>144</width>
		</image>
									<item>
				<title>New Data Confirm Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Sleep Disturbance for People With Restless Legs Syndrome (RLS)</title>
				<description>INGELHEIM, Germany, April 17 /PRNewswire/ -- A new study has shown that pramipexole (Mirapexin(R)/Sifrol(R)) can
significantly reduce sleep disturbance, often the most troublesome symptom
experienced...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/811</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/811</guid>
				<pubDate>Thu, 17 Apr 2008 07:00:00 +0000</pubDate>
			</item>
					<item>
				<title>The Institute of Psychoanalysis to Act as Expert Resource for the Media</title>
				<description>LONDON, April 2 /PRNewswire/ -- The Institute of Psychoanalysis is offering itself as a resource for
press and media, with a group of expert spokespeople available to comment on
current affairs,...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/660</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/660</guid>
				<pubDate>Wed, 02 Apr 2008 08:00:00 +0000</pubDate>
			</item>
					<item>
				<title>Dore Victims Offered Hope by Program Originator</title>
				<description>PALM BEACH GARDENS, Florida, June 3 /PRNewswire/ -- The recent announcement that Welsh businessman Wynford Dore&#039;s DDAT UK
company has entered into Administration (liquidation), followed by...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1140</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1140</guid>
				<pubDate>Tue, 03 Jun 2008 17:29:00 +0000</pubDate>
			</item>
					<item>
				<title>Retaining Employees&#039; Capacity For Work Following Sickness</title>
				<description>BERLIN, June 4 /PRNewswire/ -- How can businesses retain employees&#039; capacity for work following sickness
and disablement? Experts from throughout the world will address this question
at the 4th...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1141</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1141</guid>
				<pubDate>Wed, 04 Jun 2008 08:30:00 +0000</pubDate>
			</item>
					<item>
				<title>More People With Down Syndrome Are Being Born, Achieving More and Living Longer Than Ever Before</title>
				<description>PORTSMOUTH, England, September 16 /PRNewswire/ -- A new analysis shows that many more babies are being born with Down
syndrome today than 15 years ago in England, despite universally...</description>
				<link>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1729</link>
				<guid>http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1729</guid>
				<pubDate>Tue, 16 Sep 2008 11:00:00 +0000</pubDate>
			</item>
						<atom:link href="http://pharmalicensing.com/public/public/news/mostviewedrss/411/Handicapped_Disabled" rel="self" type="application/rss+xml" />
	</channel>
</rss>
